⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ONO-4538 Phase I Study in Patients With Solid Tumor

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: ONO-4538 Phase I Study in Patients With Solid Tumor

Official Title: ONO-4538 Multicenter, Open-label, Uncontrolled, Phase I Study in Solid Tumor

Study ID: NCT02261285

Interventions

ONO-4538

Study Description

Brief Summary: The objective of the study is to investigate the pharmacokinetics of ONO-4538 administered to Korean patients with advanced or recurrent solid tumors who are refractory or intolerant to standard therapy or for whom no appropriate treatment is available.

Detailed Description:

Keywords

Eligibility

Minimum Age: 20 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Seongnam-si Clinical Site 105, Seongnam-si, Gyeonggi-do, Korea, Republic of

Seoul Clinical Site 101, Seoul, , Korea, Republic of

Seoul Clinical Site 102, Seoul, , Korea, Republic of

Seoul Clinical Site 103, Seoul, , Korea, Republic of

Seoul Clinical Site 104, Seoul, , Korea, Republic of

Contact Details

Name: Mitsunobu Tanimoto

Affiliation: Ono Pharmaceutical Co. Ltd

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: